Image

Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)

Recruiting
Both
Phase N/A

This study looks at people who have had a certain type of stroke (called acute ischemic stroke or AIS), caused by a blockage in a large blood vessel (known as large vessel occlusion or LVO). Normally, a treatment called endovascular therapy (EVT) is used within 24 hours of a stroke. This study, called TRACK-LVO Late, examines if EVT is helpful beyond 24 hours. EVT is a procedure where doctors use tiny tools inside the blood vessels to remove the blockage and restore blood flow. The study also compares EVT to the best medical treatment (BMT) available when EVT isn't used. The study will run from January 1, 2018, to January 1, 2028, and includes patients who had a stroke over 24 hours ago. Patients will have to undergo imaging tests like CT or MRI to confirm the stroke and large vessel blockage. It aims to see which treatment works better for these patients.

  • The study includes patients from several centers over 10 years.
  • Participants will receive either EVT or the best available medical treatment.
  • Only patients without any brain bleeding can join.
Study details
    Endovascular Thrombectomy
    Large Vessel Occlusion
    Acute Ischemic Stroke

NCT06200753

Tianjin Huanhu Hospital

24 January 2024

Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.